CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Lower urinary tract symptoms in men, age-related (including symptoms of benign prostatic hyperplasia/hypertrophy) - How up-to-date is this topic?
Changes
Version 1.0, revision planned in 2014.
Last revised in August 2010
April to August 2010 — this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.
This CKS topic replaces the former topic on Prostate - benign hyperplasia.
The scope of this topic includes that of the previous topic on Prostate - benign hyperplasia, and also includes the management of voiding symptoms, urinary retention, stress incontinence, overactive bladder, nocturnal polyuria, and post-voiding symptoms. With one notable exception, all the management recommendations in Prostate - benign hyperplasia have been included in this topic. The new recommendation is that men who continue to have storage symptoms despite treatment with an alpha blocker should be offered combination therapy with an antimuscarinic agent and an alpha blocker. In addition the term 'symptoms of benign prostatic hyperplasia' is no longer used because it is thought to be misleading.
© NHS Institute for Innovation and Improvement